Business News

Adastra Holdings Notches Flower Sales License from Health Canada | 2021-12-21 | Investing News

Adastra Labs Holdings Ltd. (CSE.XTRX, OTC: XTXXF, Forum) – a leader in innovative ethnobotanical and cannabis science products – announced that its wholly-owned subsidiary Adastra Labs Inc. has recived its flowers sales license amendment from Health Canada.

The amendment is effective as of Decmeber 17, 2021 and will enable Adastra Labs to sell dried cannabis flower products in both provinces and territories across Canada through authorized distributors and retailers.

“Receiving our flower sales license is a significant milestone and provides Adastra with an additional pathway to pursue higher-margin revenue growth within the Canadian cannabis market,” Donald Dinsmore, COO & Director of Adastra Labs Holdings, said.

Read the full press release here.

New to investing in Cannabis? Check out Stockhouse tips on How to Invest in Cannabis Stocks and some of our Top Cannabis Stocks.

For more of the latest info on Cannabis, check out the Cannabis Trending News hub. Or, for lively sector discussion, visit Stockhouse’s new Cannabis Bullboards page.

FULL DISCLOSURE: Adastra Holdings Ltd. is a client of Stockhouse Publishing.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *